Empowering Healing Through Innovative Therapeutic Antibodies

今年是华人抗体协会成立十周年，为了庆祝并纪念协会十年来的光辉历程，我们诚邀您分享难忘故事！无论您是携手共进的伙伴，还是关注我们的朋友，期待您的真挚来稿，共庆协会十年华诞。投稿地址：chabs.10years@chabs.org 。此文是这个系列的第一篇，作者为协会创始人王守业博士。 望着窗外茫茫白雪，自己思绪万千，作为华人抗体协会(ChAbS)的创始人、首任会长和现任董事，在协会成立10周年之际，深感有千言万语要说，然而由于篇幅所限，本文我主要聚焦协会是如何创办的以及协会期刊《Antibody Therapeutics》创办、AntibodyPlus概念的提出、对外合作，文末还简要提及自己协会主要成就的简单总结和对协会未来10十年发展的一些个人期望。 华人抗体协会首届（2017）年会上首届执委会（EC)成员和年会的演讲嘉宾合影 华人抗体协会是如何创办的？ 在2015 年时，我在波士顿地区的一家跨国大药企工作，所在的小部门是分析技术开发，大部门是工艺开发，所以周围的同事们的背景和强项都是CMC(Chemistry, Manufacturing,

Antibody Therapeutics is delighted to announce the inaugural Antibody Therapeutics Papers of the Year Award, recognizing exceptional articles published in the previous year. Following polls conducted among thousands of global professionals through professional networks, we are thrilled to honor four outstanding papers published in 2025 as recipients of the Papers of the Year 2025 Award. The awards will be officially presented at the Antibody Therapeutics Symposium, an inaugu

We’re thrilled to announce that ChAbS  LinkedIn page has officially surpassed 20,000 followers ! This milestone reflects the growing global community that shares our mission — to connect industry, academia, and investment and advance innovation in antibody therapeutics. A heartfelt thank you to all our members, partners, and supporters for being part of this journey. Your engagement inspires us to keep building a stronger platform for collaboration and knowledge exchange. Fol